Welliver C, Feinstein L, Ward JB, et al. - Despite having a greater risk of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) than younger men, older men were less likely to receive testing at diagnosis. Poor recommended testing with urinalysis was evident despite higher prevalence of bladder cancer in older men and a standard recommendation for urinalysis since 1994. Providers are recommended to be more cognizant of AUA Guidelines when evaluating LUTS/BPH cases.

• Two insurance claims databases and a cohort of men newly diagnosed with LUTS/BPH were analyzed to determine provider adherence to American Urological Association guidelines for LUTS/BPH.

• An increase in LUTS/BPH prevalence and incidence was evident with increasing age but evaluation testing became less common.

• Urinalysis was conducted in <60% of incident patients, despite it being the most common testing type.

• Across age groups, the second most common test (range: 15–34%) was serum prostate-specific antigen.

• With increasing age, a rise in prevalence of comorbid bladder cancer (range: 0–4%), but not of bladder stones (range: 1–2%), was evident.